Observational studyJournal of managed care & specialty pharmacy2015

Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis.

Meredith Y Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.